Dr. Gabriella Ferrandina

Brief Biography:

---

Education:

July 1983: High School

October-1989: Degree in Medicine with Honors at theCatholicUniversityRome

November-1994: Residency in Obstetrics/Gynecology with Honors at theCatholicUniversityRome

August 1995 - July 1996:  Training program at the MD Anderson Cancer Center, Houston.

October  1998: Residency in Clinical Pathology with Honors at theCatholicUniversityRome

Since 1996 AssistantProfessor at the Department  of  Gynecologic Oncology,CatholicUniversity,Rome

Since May 2007 Head of the Gynecologic Oncology Unit,CatholicUniversity, Campobasso

TOEFL and TWE obtained

Academic positions:

---

Assistant Professor

Head of the Gynecologic Oncology Unit

Dept. Oncology

Catholic University, Campobasso, Italy

Research interests:

---

Trnslational research

Phase II,III clinical trials

Chemotherapy

Gynecologic Oncology

Any other information:

---

Membership:

-European Society of Mastology (1996)

-Associate Member della American Association for Cancer Research (1996,1997,1998)

-Corresponding Member American Association for Cancer Research (1999,2000,2001,2002,2003,2004.2005,2006,2007,2008,2009,2010)

-Member of the American Society of Clinical Oncology (2005,2006,2007,2008,2009,2010,2011)

- Italian Society of Gynecologic Oncology (2007/08/2009/2010/2011)

-Italian Society of Psycho-oncology (SIPO) (2009/2010/2011)

-Member of  MITO Group (Multicenter Italian Trial in Ovarian Cancer (2005-2011)

-Associate Member  of American Association for Cancer Research (1996,1997,1998)

-Corresponding Member of  American Association for Cancer Research (since 1999)

Referee for the following Journals

    Anticancer Drugs
    Archives of Gynecology and Obstetrics
    The  American Journal of Medical Sciences
    Biomarkers
    BMC Cancer
    BMC Women’s Health
    Br J Cancer
    Cancer Biology and Therapy
    Cancer Epidemiology
    Cancer Epidemiology,  Biomarkers and Prevention
    Cancer Immunology Immunotherapy
    Cancer Investigation
    Cancer Letters
    Cell Proliferation
    Clinical Chemistry and Laboratory Medicine
    Clinical Medicine: Therapeutics
    Current Cancer Therapy Review
    Current Cancer Drug Targets
    Current Pharmaceutical Biotechnology
    Drugs
    Eur J Cancer
    Eur J Obstetrics & Gynecology and Reproductive Biology
    Eur J Surgical Oncology
    Expert Opinion on Drug Metabolism and Toxicology
    Expert Opinion on Investigational drugs
    Expert Review of Anticancer Drugs
    Expert Review Obstetrics and Gynecology
    Future Oncology
    Gene Therapy and Molecular Biology
    Gynecologic Obstetric Investigation
    Gynecologic Oncology
    HIstology and Histopathology
    Human Reproduction
    Immunological Investigations
    Indian Journal of Cancer
    Int J Cancer
    Int J Gynecological Cancer
    J Experimental and Clinical Cancer Research
    Journal of Cellular and Molecular Medicine
    J Medical Case Reports
    J Molecular Endocrinology
    J Nuclear Medicine and Radiation Therapy
    J Pathology
    Minerva Ginecologica
    Minerva Medica
    Molecular Human Reproduction
    Nanomedicine
    Obstetrics and Gynecology
    Oncology
    Recent Patents on anti-cancer Drug discovery
    Reproductive Biology and Endocrinology
    Therapeutics and Clinical risk Management
    Thrombosis and Haemostasis
    Trend Pharmacological Sciences
    Tumori
    Tumour Biology
    The Lancet
    The Lancet Oncology
    Womens’s Health
    World J Surg Oncol

Since 2009: Associate Member of the Editorial Board of BMC Cancer

Since 2010: Associate Member of the Editorial Board of European Journal od Surgical Oncology (for Gynecologic Oncology)

Since 2010: Member of the Editorial Board International Scholarly Research  Network (ISRN) Oncology

Since February 2010: Executive Guest Editor for Current Pharmaceutical Design

Since October 2011: Member of the Editorial Board of the European Journal of Cancer

Since October 2011: Member of the International Evaluation Committee of  Association pour le Recherche (ARC) sur le Cancer and Ligue Nationale contre le  Cancer (LNCC)

-Referee Internazionale per la valutazione dei Progetti Scientifici presentati alla “Translational Research in Clinical trials Committee” (Cancer Research, UK).

-Referee Internazionale per la valutazione di Clinical Trials : “Study of the AGO (Arbeitgemeinschaft Gynakologische Onkologie) uterus group/ARO”

-Referee Internazionale per la valutazione dei Progetti Scientifici presentati alla “Clinical Trials Awards and Advisory Committee” (Cancer Research, UK).

-Referee Internazionale per la valutazione Dei progetti Scientifici presentati alla “Wellcome Trust Company” (UK).

-Referee of the  “Translational Research in Clinical trials Committee” (Cancer Research UK).

-Referee of  Clinical Trials : “Study of the AGO (Arbeitgemeinschaft Gynakologische Onkologie) uterus group/ARO”

Dr Ferrandina is author of more than 260 publications in International Journals (www.pubmed.com)

What I think of the idea behind WebmedCentral:

---

It represents the best way to share knowledge in a fast, effective, trasversal way